Gene · 871
SERPINH1: serpin family H member 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SERPINH1: serpin family H member 1. Genes, record 871. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/871
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P50454 | Serpin H1 | 418 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents160
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 12540940 B2 | 2026-02-03 | 51 | P50454 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 7514 | P50454 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 12127 | P50454 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 12128 | P50454 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 12130 | P50454 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2309 | P50454 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 3240 | P50454 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 3285 | P50454 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7693 | P50454 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7693 | P50454 | Espacenet |
1 to 10 of 160
See all 160 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,591
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SERPINH1 papers | Newest fiscal year |
|---|---|---|---|
| ZIAHD000256 | Collagen-related diseases | 9 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P01CA100730 | Retrovirus Models of Cancer | 6 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 5 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| ZIAHD002400 | The Role Of Subclinical Infection And Cytokines In Preterm Parturition | 4 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 3 | 2025 |
| P20GM103429 | Partnerships for Biomedical Research in Arkansas | 3 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 3 | 2025 |
1 to 10 of 1,591Source NIH's project files
See all 1,591 nih grantsPapers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The anion channel GPR89 is a tumor-specific dependency in breast cancer. | Nat Commun | 2026 | 42773111 | PubTator, text mining | PubMed |
| FAPi-Mediated siRNA Lipid Nanoparticles for the Treatment of Liver Fibrosis. | Small | 2026 | 42753175 | PubTator, text mining | PubMed |
| HSP47 in Mitochondria: Roles in Apoptosis, Signal Transduction, and Protein and Virus Transportation. | Cells | 2026 | 42738895 | PubTator, text mining | PubMed |
| Backbone and side chain 1H, 13C and 15N chemical shift assignment of the cargo-recognition domain MOTH of human TANGO1. | Biomol NMR Assign | 2026 | 42726333 | PubTator, text mining | PubMed |
| Controlled delivery of Cu2+ and Zn2+ ions from chitosan scaffolds: media-dependent release of ions and its influence on cellular responses relevant to wound healing. | J Mater Chem B | 2026 | 42689464 | PubTator, text mining | PubMed |
| SERPINH1 derived from cancer-associated fibroblasts promotes epithelial-mesenchymal transition in clear cell renal cell carcinoma. | Genes Immun | 2026 | 42637806 | PubTator, text mining | PubMed |
| Ubiquitin-Related Proteostatic Programs in Cycling Fibroblast-Lineage Remodeling After Myocardial Ischemic Injury: A Hypothesis Informed by Single-Cell and Spatial Transcriptomics. | Int J Mol Sci | 2026 | 42511877 | PubTator, text mining | PubMed |
| SERPINH1 expression represents a reliable biomarker of human breast cancer aggressiveness. | Biol Direct | 2026 | 42464413 | PubTator, text mining | PubMed |
| Cell-type signatures of Alzheimer's disease shared across population groups. | Nature | 2026 | 42457956 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis identifies key microglial subpopulations and therapeutic targets in Parkinson's disease. | Parkinsonism Relat Disord | 2026 | 42430983 | PubTator, text mining | PubMed |
1 to 10 of 3,090
See all 3,090 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/871
GET https://conductscience.org/api/genes/v1/871/patents?page=2